A method for obtaining fetal heart rate which includes: transmitting an ultrasonic pulse wave (110) towards an abdomen of a pregnant woman according to a preset period; receiving a pulse echo and a fetal heart echo corresponding to the ultrasonic pulse wave in each of the periods, and processing the pulse echo and the fetal heart echo independently to obtain a corresponding pulse rate of the pregnant woman and the fetal heart rate (130); outputting the fetal heart rate (150) when a difference value between the fetal heart rate and the pulse rate of the pregnant woman is not lower than a preset threshold. Furthermore, a system and an apparatus for obtaining fetal heart rate are also provided. The method and terminal for obtaining a fetal heart rate improves accuracy of the obtained fetal heart rate.

This invention relates to an ingestible drug delivery device configured for wireless communication with other ingestible drug delivery devices.

The invention relates to a method to automatically predict a calving moment of a cow, comprising: recording, by a three-dimensional camera system, at least one three-dimensional image of the cow, processing, by a processing device, the at least one image of the cow, wherein processing of the image comprises determining a parameter indicative of the calving moment, and predicting a calving moment of the cow on the basis of the parameter.

A method of assessing uterine parameters via a apparatus including a processor includes determining, by the processor, at least one uterine parameter based on one or more ultrasound images of a uterus of a subject, the one or more ultrasound images being obtained on predefined days within an IVF cycle of the subject, tracking, by the processor, a change in the at least one uterine parameter, and predicting, by the processor, success of embryo implantation based on the change in the at least one uterine parameter.

Technology is disclosed for a cat litter that can be used to diagnose feline medical conditions. A cat litter contains an additive, e.g., a chemical agent, such as a natural and/or synthetic agent, that changes in color when it comes in contact with cat urine or feces. Based on the color it can be determined whether the cat has a medical condition, such as particular illness. For example, if the litter turns yellow when it comes in contact with the urine, it can indicate that the cat is healthy. If the litter turns to a color other than yellow, e.g., green, it can indicate that the cat has some illness. The cat then be taken to a veterinary doctor for further diagnosis. The chemical agent aids in detection and diagnosis through interaction of materials that change colors to indicate reactions with specific chemicals, cells, molecules, DNA and/or materials. The technology can be implemented for medical diagnosis and detectionfor humans and/or animals.

An apparatus for detecting and notifying occurrence of post-partum haemorrhage in female patients is envisaged. Continued tracking of the blood discharged from a female patient's body during labor as well as postnatal operation procedures is provided for, and as soon as the amount of blood discharged from the body of the female patient exceeds a predetermined threshold value, a light-based alarm and sound-based alarm are triggered. The apparatus includes a first connector connected to the female patient when she is on a Labor Recovery Delivery bed, and a second connector woven onto an undergarment to be worn by the female patient. The first connector and second connector are connected to single use, disposable blood collection bags, whose weights are measured using weight sensors for an accurate calculation of the total amount of the blood lost by the female patient during labor operation procedures and postnatal operation procedures.

Utilizing a computing device to generate a personalized maternal nutrition plan for a pregnant mother. The computing device receives real-time maternal physiological data, fetal physiological data, and real-time environmental data associated with the pregnant mother. A real-time relationship is established. The real-time relationship is compared with historically established relationships between pregnant mothers and fetuses. The maternal physiological data is compared with pre-pregnancy data of the pregnant mother. The computing device detects one or more abnormalities in the real-time established relationship between the pregnant mother and the fetus based upon the comparison of the real-time established relationship with historically established relationships and the comparison of the maternal physiological data with pre-pregnancy data of the pregnant mother. The computing device generates a maternal nutrition plan. A notification is generated by the computing device and outputted to one or more electronic devices associated with the pregnant mother and/or one or more physicians.

Methods and system are described for multi-modal, multi-parametric, non-invasive, and real-time assessment of cervical tissue through a multi-modal probe device for use within a vaginal canal and an associated imaging system to assess a risk of preterm delivery of an expectant mother. The multi-modal system may include ultrasound (US) imaging, viscoelastic (VE) imaging, and/or photoacoustic (PA) imaging of the cervical issue to determine cervical biomarker information indicative of parameters including, but not limited to, a collagen to water ratio such that a more water dominant ratio is indicative of a risk of preterm delivery.

This invention relates to an ingestible drug delivery device configured for wireless communication with other ingestible drug delivery devices.

The present application provides a health monitoring method, a wearable device, a health monitoring system, and a computer readable storage medium. The health monitoring method includes: acquiring pregnant woman health reference information; transmitting the pregnant woman health reference information and pregnant woman identity information in the wearable device to a remote medical server terminal; and receiving pregnant woman health diagnosis information from the remote medical server terminal, wherein the pregnant woman health diagnosis information is determined according to the pregnant woman health reference information and the pregnant woman identity information.